ArticleAmerican heart journal plus : cardiology research and practice2026
The incremental prognostic effect of red blood cell distribution width in 28-day mortality among critically ill patients with HFpEF.
Article in American heart journal plus : cardiology research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The prognostic impact of red blood cell distribution width (RDW) on adverse outcomes in patients with heart failure with preserved ejection fraction (HFpEF) has been established. However, its non-linear relationship and incremental prognostic value in critically ill HFpEF patients remain insufficiently explored. Methods: A retrospective cohort study was conducted involving 3802 HFpEF patients from the Medical Information Mart for Intensive Care IV (MIMIC-IV, v3.1) database. Multivariable Cox regression and restricted cubic spline (RCS) analyses were performed to evaluate the association between RDW and 28-day mortality, adjusting for potential confounders. A prediction model was constructed by the least absolute shrinkage and selection operator (Lasso)-Cox regression, and receiver operating characteristic (ROC) curve was utilized to assessed the incremental prognostic effect of RDW on 28-day mortality prediction. Results: Within the final cohort of 1962 HFpEF patients, the incidence of 28-day mortality showed a significant increase across RDW tertiles (T1 9.4% vs T2 13.1% vs T3 22.9%, Conclusions: This study established a significant linear association between RDW at admission and poor prognosis in critically ill patients with HFpEF. Higher RDW levels were associated with increased 28-day mortality risk, suggesting that it may be a relevant biomarker for mortality risk stratification in HFpEF patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.